- In June 2024, IDEXX Laboratories introduced the Catalyst Pancreatic Lipase Test, designed to provide quantitative results in under 10 minutes, aiding veterinarians in the rapid diagnosis and treatment of pancreatitis in dogs and cats
- In May 2024, Mars, Incorporated entered exclusive discussions to acquire Cerba HealthCare’s stake in Cerba Vet and ANTAGENE, aiming to enhance its European veterinary diagnostics business through Mars Petcare’s Science & Diagnostics division
- In January 2024, GD Animal Health, based in the Netherlands, acquired PathoSense diagnostics to advance its diagnostic capabilities, focusing on identifying all viruses and bacteria using nanopore sequencing technology
- In February 2024, IDEXX Laboratories launched Vello, a pet owner engagement software solution designed to streamline connections between veterinary practices and clients. Vello integrates with IDEXX practice management software, offering features such as automated reminders, health service alerts, and a user-friendly mobile web platform for easy access to pet records and appointment scheduling
- In November 2022, VolitionRx Limited launched its Nu.Q Vet Cancer Screening Test across the U.S. and Europe through Heska Corporations' veterinary diagnostic laboratories
